Oncology

More links

• 2025 PublicationsResearch Published in 2025
• 🔗Evaluating the impact of Keep Your Move in the Tube (KYMITT) on patient AM-PAC scores and discharge dispositionMattox, M., Ennis, J., McClain, M., Trinidad, J., Bajorek, A., Fonseca, T., West, K., King, T., & Lazensky, R. (2025). Evaluating the impact of Keep Your Move in the Tube (KYMITT) on patient AM-PAC scores and discharge disposition. PM & R : the journal of injury, function, and rehabilitation, 10.1002/pmrj.13315. Advance online publication. https://doi.org/10.1002/pmrj.13315
• 🔗 The Moderating Effects of Time Since Cancer Treatment of the Mindfulness-Based Stress Reduction (MBSR(BC)) on Cognitive Functioning Among Breast Cancer Survivors. A poster presentation at thLengacher, C. A., Reich, R. R., Rodriguez, C. S., Tinsley, S., Meng, H., Drobisz, J., Lucas, J., Fonseca, T., Nidamanur, S., Joshi, A., Wang, J., Krothapalli, M., Surdovel, A., Acosta, M., Hornback, E., Patel, D., & Park, J. Y. (2025). The Moderating Effects of Time Since Cancer Treatment of the Mindfulness-Based Stress Reduction (MBSR(BC)) on Cognitive Functioning Among Breast Cancer Survivors. Psycho-oncology, 33(S1), 40. [doi.org]https://doi.org/10.1002/pon.6288 [doi.org]
• ► 2024 PublicationsResearch published in 2024:
• 🔗The Moderating Role of Genetics on the Effectiveness of the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) Program on Cognitive ImpairmentPark, J. Y., Lengacher, C. A., Rodriguez, C. S., Meng, H., Kip, K. E., Morgan, S., Joshi, A., Hueluer, G., Wang, J. R., Tinsley, S., Cox, C., Kiluk, J., Donovan, K. A., Moscoso, M., Bornstein, E., Lucas, J. M., Fonseca, T., Krothapalli, M., Padgett, L. S., Nidamanur, S., … Reich, R. R. (2024). The moderating role of genetics on the effectiveness of the mindfulness-based stress reduction for breast cancer (MBSR(BC)) program on cognitive impairment. Biological Research for Nursing, .https://doi.or
• 🔗The Effect of Self-efficacy–Enhancing Interventions on Quality of Life of Cancer Survivors A Systematic ReviewYan, K., Lengacher, C. A., Dandamrongrak, C., Wang, H. L., Hanson, A., & Beckie, T. (2024). The effect of self-efficacy-enhancing interventions on quality of life of cancer survivors: A systematic review. Cancer Nursing, 10.1097/NCC.0000000000001372. https://doi.org/10.1097/NCC.0000000000001372
• 🔗 Radiofrequency ablation of renal tumors 3-7 cm with direct real-time temperature monitoring using nonconducting fiberoptic thermistors: Technique and 14-year follow-up of oncologic and renal(Gastro-Intestinal) Benjamin Behers,1 Spencer Kortum,1 Genesis Dolgetta,2 Tonya S. King,2 and Robert I. Carey1 1 Florida State University College of Medicine 1 Sarasota Memorial Hospital Research Institute2 RADIOFREQUENCY ABLATION OF RENAL TUMORS 3-7 CM WITH DIRECT REAL TIME TEMPERATURE MONITORING USING NONCONDUCTING FIBEROPTIC THERMISTORS: TECHNIQUE AND 14-YEAR FOLLOW UP OF ONCOLOGIC AND RENAL FUNCTION OUTCOMES
• 🔗 Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system(Hematology) Abby Rose Broomfield, PharmD Candidate; Morgan LaMarc, PharmD Candidate; Sierra Parsons, PharmD Candidate Bren Magruder, PharmD; Justin Presutto , PharmD, MBA, BCOP Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system
• 🔗 Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system(Hematology) Broomfield, A.R.; LaMarc, M.T.; Parsons, S.R.; Magruder, B.D.; Presutto, J.T.* Evaluation of a novel sequential treatment protocol for acute immune thrombocytopenia at a large community health care system
• 🔗 Examination of Changes in Mindfulness and Rumination Among Breast Cancer Survivors who Participated in a Mindfulness-Based Stress Reduction Program Compared to Breast Cancer EducationLengacher, C. A., Reich, R. R., Rodriguez, C. S., Meng, H., Tinsley, S., Drobisz, J., Hagen, L., Lucas, J., Fonseca, T., Hueluer, G., Wang, J., Nidamanur, S., Krothapalli, M., Surdovel, A., Acosta, M., Patel, D., Hornback, E., & Park, J. Y. (2024). Examination of Changes in Mindfulness and Rumination Among Breast Cancer Survivors Who Participated in a Mindfulness-Based Stress Reduction Program Compared to Breast Cancer Education Program or Usual Care. Psycho-oncology, 33(S1), 17
• 🔗 Examination of the Role of Genetics and Implementation of a Mindfulness-Based Stress Reduction (MBSR(BC)) Program in Treating Cognitive Impairment Among Breast Cancer SurvivorsLengacher, C. A., Reich, R. R., Rodriguez, C. S., Tinsley, S., Meng, H., Nidamanur, S., Lucas, J., Fonseca, T., Joshi, A., Krothapalli, M., Wang, J., Surdovel, A., Acosta, M., Hornback, E., Patel, D., Kip, K., & Park, J. Y. (2024). Examination of the Role of Genetics and Implementation of a Mindfulness-Based Stress Reduction (MBSR(BC)) Program in Treating Cognitive Impairment Among Breast Cancer Survivors. Psycho-oncology, 33(S1), 40
• 🔗 Esophageal cancer in Hispanics: A propensity score matched analysis of the National Cancer Database.Meredith, K. L., Huston, J., & Shridhar, R. (2024). Esophageal cancer in Hispanics: A propensity score matched analysis of the National Cancer Database. Journal of Clinical Oncology, 42(3_suppl), 258–258. https://doi.org/10.1200/JCO.2024.42.3_suppl.258
• 🔗 Socioeconomic status predicts treatment patterns in Hispanics with pancreatic cancerMeredith K, Huston J, Shridhar R. Socioeconomic status predicts treatment patterns in Hispanics with pancreatic cancer. Ann Surg Oncol. 2024; 31 (Suppl. 1): 146. DOI: 10.1245/s10434-024-15179-y
• 🔗 Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Nguyen, A. T., Park, J. Y., Meng, H., Tinsley, S., Hueluer, G., Donovan, K. A., Moscoso, M. S., Bornstein, E., Kiluk, J., Nidamanur, S., Padgett, L. S., Lucas, J. M., Fonseca, T., Joshi, A., Lin, K. J., Goodman, M., & Kip, K. E. (2024). Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial. Journal of Integrative and Comple
• 🔗Esophageal cancer in Hispanics: A demographic analysis of the National Cancer Database.(Gastro-Intestinal) Ricardo J, Alkayali T, Shridhar R, Huston J, Meredith K. Esophageal cancer in Hispanics: A demographic analysis of the National Cancer Database. J Gastrointest Surg. 2024;28(7):1126-1131. doi: 10.1016/j.gassur.2024.05.010.
• 🔗Evaluation of management strategies for hepatocellular carcinoma.Meredith K, Huston J, Shridhar R. Evaluation of management strategies for hepatocellular carcinoma. HPB.2024;26 (Suppl 2): S683. doi.org/10.1016/j.hpb.2024.04.188(2024)
• 🔗Evaluation of anastomotic technique in patients undergoing transthoracic esophagectomy.Meredith K, Huston J, Shridhar R. Evaluation of anastomotic technique in patients undergoing transthoracic esophagectomy. Surg Endosc. 2024;38 (Suppl 1): 104-353. doi: 10.1007/s00464-024-10893-w (2024)
• 🔗 A Randomized Clinical Trial of Mindfulness-Based Stress Reduction Program Among Breast Cancer Survivors Post-Treatment: Evaluating Mediators of Cognitive Improvement.Lengacher, C. A., Hueluer, G., Wang, J. R., Reich, R. R., Meng, H., Park, J. Y., Kip, K. E., Morgan, S., Joshi, A., Tinsley, S., Krothapalli, M., Nidamanur, S., Cox, C., Kiluk, J., Lucas, J. M., Fonseca, T., Moscoso, M. S., Bornstein, E., Donovan, K. A., … Rodríguez, C. C. S. (2024). A Randomized Clinical Trial of Mindfulness-Based Stress Reduction Program Among Breast Cancer Survivors Post-Treatment: Evaluating Mediators of Cognitive Improvement. https://doi.org/10.1089/jicm.2024.0493
• 🔗Malignant Epithelioid Mesothelioma of the Tunica Vaginalis Testis Presenting as Hydrocele in a Kidney Transplant RecipientBehers, B. M., Guske, C. W., Behers, B. J., Kortum, S. B., Bermingham, I. G., Warner, C. L., & Carey, R. I. (2024). Malignant Epithelioid Mesothelioma of the Tunica Vaginalis Testis Presenting as Hydrocele in a Kidney Transplant Recipient. Case Reports in Urology, 9227764. https://doi.org/10.1155/2024/9227764
• 🔗In-hospital outcomes of autologous stem cell transplantation in patients with multiple myeloma with versus without heart failure.Garcia, G., Rosario, M., Vazquez, M., Hameed, M., Vargas, I., Wiese-Rometsch, W. & Nair, J. (2024). In-hospital outcomes of autologous stem cell transplantation in patients with multiple myeloma with versus without heart failure. Journal of Clinical Oncology, 42, e19511-e19511. doi:10.1200/JCO.2024.42.16_suppl.e19511
• 🔗TCL-732 A Rare Case of Rapid Onset Fatal HLH Secondary to Large Granular T-cell Lymphocytic Leukemia Hameed, M., Garcia, G., Apugliese, A., Namjoshi, D., Hamad, K. & Wiese-Rometsch, W. (2024). TCL-732 A Rare Case of Rapid Onset Fatal HLH Secondary to Large Granular T-cell Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia, 24. https://doi.org/10.1016/S2152-2650(24)01623-9.
• 🔗MM-559 Update on Predictors of Progression in Smoldering Multiple Myeloma: A Systematic ReviewGarcia, G., Hameed, M., Jerez, D., Pereyra, K., Rosario, M. & Kayali, F. (2024). MM-559 Update on Predictors of Progression in Smoldering Multiple Myeloma: A Systematic Review. Clinical Lymphoma Myeloma and Leukemia, 24. https://doi.org/10.1016/S2152-2650(24)01706-3.
• 🔗MM-563 Immunotherapy Revealing Promising Outcomes in Smoldering Myeloma: A Systematic ReviewGarcia, G., Hameed, m., Jerez, D., Pereyra, K., Rosario, M. & Kayali, F. (2024). MM-563 Immunotherapy Revealing Promising Outcomes in Smoldering Myeloma: A Systematic Review. Clinical Lymphoma Myeloma and Leukemia, 24. https://doi.org/10.1016/S2152-2650(24)01707-5.
• ► 2023 PublicationsResearch published in 2023:
• 🔗 Comparison of prostate biopsy grade obtained by human pathologists versus an artificial intelligence algorithm for predicting biochemical recurrence after radical prostatectomy.(Urology) Calle Claire de la, Vidotto Thiago, Erak Eric, Salles Daniela, Dairo Oluwademilade, Pavlovich Christian, Han Misop, Cho Joonyoung, Suh In Hye, Chang Hye Yoon, Kim Sun Woo, Gorin Michael, & Lotan Tamara. (2023). PD27-11 COMPARISON OF PROSTATE BIOPSY GRADE OBTAINED BY HUMAN PATHOLOGISTS VERSUS AN ARTIFICIAL INTELLIGENCE ALGORITHM FOR PREDICTING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. Journal of Urology, 209(Supplement 4), e746. https://doi.org/10.1097/JU.0000000000003305.
• 🔗 Effects of a Mindfulness-Based Stress Reduction Program Compared to a Breast Cancer-Education Support or Usual Care for Chemotherapy-Induced Peripheral Neuropathy (W29)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Meng, H., Tinsley, S., Tofthagen, C., Lucas, J., Fonseca, T., Borstein, E., Lin, K., Hueluer, G., Chauca, K., Wang, J., Acosta, M., Joshi, A., Allen, A. P., Baier, C. E., Nidamanur, S., Park, J. Y. High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness-Based Stress Reduction for Breast Cancer MBSR(BC) Program. 20th Annual APOS Conference; poster presentation; March 15-17, 2023.
• 🔗 Evaluation of a Virtual Mindfulness‐Based Stress Reduction Program for Advanced Stage Breast Cancer Survivors (vMBSR(BC)) Adapted for Black and Hispanic BCS. (T37)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Drobisz, J., Hagen, L., Meng, H., Tinsley, S., Chauca, K., Lucas, J., Fonseca, T., Acosta, M., Baier, C., Joshi, A., Nidamanur, S., Pomatto, M., Surdovel, A., Allen, A. P., Kelly, T., Akinola, B., Park, J.Y. Evaluation of a Virtual Breast Cancer Education Support Program for Advanced Stage Breast Cancer Survivors (vBCES(BC)) for Black and Hispanic Breast Cancer Survivors. Psycho-Oncology. 2023;32(S1):85 https://doi.org/10.1002/pon.6090 [
• 🔗The use of Indocyanine Green (ICYG) angiography intraoperatively to evaluate gastric conduit perfusion during esophagectomy: does it impact surgical decision making?LeBlanc G, Takahashi C, Huston J, Shridhar R, Meredith K. The use of Indocyanine Green (ICYG) angiography intraoperatively to evaluate gastric conduit perfusion during esophagectomy: does it impact surgical decision making? Surg Endosc. 2023;37(11):8720-8727. doi: 10.1007/s00464-023-10258-9. 2023
• 🔗 Timing After Neoadjuvant Therapy Predicts Mortality in Patients Undergoing Esophagectomy: a Propensity Score-Matched AnalysisMaramara, T., Shridhar, R., Blinn, P., Huston, J., & Meredith, K. (2023). Timing After Neoadjuvant Therapy Predicts Mortality in Patients Undergoing Esophagectomy: a Propensity Score-Matched Analysis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 27(11), 2342–2351. https://doi.org/10.1007/s11605-023-05851-1
• 🔗 Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study(Gastro-Intestinal) Takahashi, C., Glasser, J., Schuster, C., Huston, J., Shridhar, R., & Meredith, K. (2023). Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study. Surgical endoscopy, 10.1007/s00464-023-10204-9. Advance online publication. https://doi.org/10.1007/s00464-023-10204-9
• 🔗 A decade experience with robotic assisted trans-thoracic esophagectomy. - International Conference on Surgical Cancer Care (Page 236)(Gastro-Intestinal) LeBlanc G, Blinn P, Huston J, Shridhar R, Meredith K. A decade experience with robotic assisted trans-thoracic esophagectomy. Ann Surg Oncol. 2023; 30 (Suppl. 1): 236. doi: 10.1245/s10434-023-13332-7
• 🔗 Prediction of risk factors associated with readmission after robotic esophagectomy.(Gastro-Intestinal) Meredith, K. L., LeBlanc, G., Takahashi, C., Huston, J., & Shridhar, R. (2023). Prediction of risk factors associated with readmission after robotic esophagectomy. Journal of Clinical Oncology, 41(4_suppl), 328–328. https://doi.org/10.1200/JCO.2023.41.4_suppl.328
• 🔗 Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis(Gastro-Intestinal) Shridhar, R., Blinn, P., Huston, J., & Meredith, K. L. (2023). Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. Cancer, 129(6), 890–900. https://doi.org/10.1002/cncr.34625
• 🔗 Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm.(Gastro-Intestinal) Zureikat, A. H., Pishvaian, M. J., Lopez, C. D., Meredith, K., Zervos, E. E., Hatoum, H., Chung, K. Y., Tsobanoudis, A., Berg, D. J., Ucar, A., Nazemzadeh, R., Bates, S. E., Goodman, K. A., Johnson, T., Parikh, N., Kouri, B., Laing, C., Boone, B. A., Qureshi, I., & Agah, R. (2023). Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm. Journal of Clinical Oncology, 41(4_suppl), 714–714. https://doi.org/1
• 🔗 Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy.(Gastro-Intestinal) Pishvaian, M. J., Zureikat, A. H., Lopez, C. D., Meredith, K., Zervos, E. E., Hatoum, H., Chung, K. Y., Berg, D. J., Ucar, A., Gandhi, R. T., Nazemzadeh, R., Parikh, N., Novelli, P. M., Kouri, B., Laing, C., Boone, B. A., Johnson, T., Bates, S. E., Agah, R., & Goodman, K. A. (2023). Targeted intra-arterial gemcitabine vs. Continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresecta
• 🔗 Intra-arterial gemcitabine vs IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer.(Gastro-Intestinal) Zureikat A, Pishvaian M, Meredith K, et al. Intra-arterial gemcitabine vs. IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer. J Clin Oncol. 2023; 41(suppl 4): 728. doi: 10.1200/JCO.2023.41.3_suppl.728
• 🔗 Evaluation of a Virtual Breast Cancer Education Support Program for Advanced Stage Breast Cancer Survivors for Black and Hispanic Breast Cancer Survivors. (T38)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Drobisz, J., Hagen, L., Meng, H., Tinsley, S., Chauca, K., Lucas, J., Fonseca, T., Acosta, M., Baier, C. E., Joshi, A., Nidamanur, S., Pomatto, M., Surdovel, A., Allen, A. P., Kelly, T., Akinola, B. Park, J. Y. Evaluation of a Virtual Mindfulness‐Based Stress Reduction Program for Advanced Stage Breast Cancer Survivors (vMBSR(BC)) Adapted for Black and Hispanic BCS. Psycho-Oncology. 2023;32(S1):84-85 https://doi.org/10.1002/pon.6090 [doi
• 🔗 High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness‐Based Stress Reduction for Breast Cancer MBSR(BC) Program (W28)(Breast) Lengacher, C. A., Reich, R. R., Rodriguez, C. S., Meng, H., Tinsley, S., Tofthagen, C., Lucas, J., Fonseca, T., Borstein, E., Lin, K., Hueluer, G., Chauca, K., Wang, J., Acosta, M., Joshi, A., Allen, A. P., Baier, C. E., Nidamanur, S., Park, J. Y. High Resolution Symptom Assessment Among Breast Cancer Survivors (BCS) Enrolled in a Mindfulness‐Based Stress Reduction for Breast Cancer MBSR(BC) Program. Psycho-Oncology. 2023;32(S1):60 https://doi.org/10.1002/pon.6090 [doi.org].
• 🔗 Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.(Gastro-Intestinal) Goodman K, Pishvaian M, Lopez C, Meredith K, et al. Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial. J Clin Oncol. 2023; 41(suppl 4): 713. doi: 10.1200/JCO.2023.41.3_suppl.713
• ► 2022 PublicationsResearch published in 2022:
• 🔗Oncologic outcomes of laparoscopic, robotic and open gastrectomy.Glasser J, Schuster C, Huston J, Shridhar R, Meredith K. Oncologic outcomes of laparoscopic, robotic and open gastrectomy. Ann Surg Oncol. 2022; 29 (Suppl. 2): 500-1. doi: 10.1245/s10434-022-11828-2 E235
• 🔗 Comparative outcomes of minimally invasive and robotic esophagectomy.Schuster C, Glasser J, Huston J, Shridhar R, Meredith K. Comparative outcomes of minimally invasive and robotic esophagectomy. Ann Surg Oncol. 2022; 29 (Suppl. 2): 497. doi: 10.1245/s10434-022-11828-2
• 🔗Correlation of surgical volume and outcomes with gastrectomy.Schuster C, Glasser J, Huston J, Shridhar R, Meredith K. Correlation of surgical volume and outcomes with gastrectomy. J Clin Oncol. 2022; 40(suppl 4): 272. doi: 10.1200/JCO.2022.40.4_suppl.272
• 🔗Comparative outcomes of minimally invasive and open gastrectomy.Glasser J, Schuster C, Huston J, Shridhar R, Meredith K. Comparative outcomes of minimally invasive and open gastrectomy. J Clin Oncol. 2022; 40(suppl 4): 271. doi: 10.1200/JCO.2022.40.4_suppl.271
• 🔗 The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-Oncology Click to view full text Publication(Cardiology) Gardner, A., & Taylor, A. (2022, June). The Longer You Wait, the Harder It Gets: A Case for Adoption of Strain Imaging in Cardio-Oncology. 11(6), 8–11.
• 🔗 Hemorrhagic Chemosis Associated With lsatuximab Use in an Elderly Lady With Multiple Myeloma.(Hematology) Idogun, P. O., & Kayali, Z. (2022). Hemorrhagic Chemosis Associated With Isatuximab Use in an Elderly Lady With Multiple Myeloma. Cureus, 14(3), e22764. https://doi.org/10.7759/cureus.22764
• 🔗 "A Case Report of Plasmablastic Lymphoma with Unusual Presentation: How Do Socioeconomic Factors Contribute to Cancer Survival?"(Hematology) Idogun, P., Rebernigg, J., Teklie, Y., King, A., & Ke, N. (2022). A Case Report of Plasmablastic Lymphoma with Unusual Presentation: How Do Socioeconomic Factors Contribute to Cancer Survival? Frontiers in Medical Case Reports, 03(04). https://doi.org/10.47746/FMCR.2022.3402
• 🔗 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6.Falchook, G. S., Patel, M. R., Ulahannan, S. V., Maier, D., Hipp, S., Azuma, H., & Spigel, D. R. (2022). A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6. Journal of Clinical Oncology, 40(16_suppl), TPS3175–TPS3175. https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS3175
• 🔗Takahashi C, Shridhar R, Huston J, Meredith K. Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis. Pancreatology.Takahashi C, Shridhar R, Huston J, Meredith K. Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis. Pancreatology. 2022;22(3): 396-400. doi: 10.1016/j.pan.2022.03.008 2022
• 🔗 Correlation Between Lymph Node Resection and Survival in Patients with Pancreatic Cancer.LeBlanc, Gabrielle MS; Shridahr, Ravi MD, PhD; Huston, Jamie MS,; Meredith, Kenneth L MD, FACS, FSSO. Correlation Between Lymph Node Resection and Survival in Patients with Pancreatic Cancer. Journal of the American College of Surgeons 235(5):p S149, November 2022. | DOI: 10.1097/01.XCS.0000894112.37625.f1
• 🔗Relationship between surgical volume and outcomes with minimally invasive pancreatic resection. Glasser J, Schuster C, Huston J, Shridhar R, Meredith K. Relationship between surgical volume and outcomes with minimally invasive pancreatic resection. Ann Surg Oncol. 2022; 29 (Suppl. 2): 451-2. doi: 10.1245/s10434-022-11828-2 E116
• ► 2021 PublicationsResearch published in 2021:
• 🔗 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer.(Gastro-Intestinal) Qiu, B., Cai, K., Chen, C., Chen, J., Chen, K. N., Chen, Q. X., Cheng, C., Dai, T. Y., Fan, J., Fan, Z., Hu, J., Hu, W. D., Huang, Y. C., Jiang, G. N., Jiang, J., Jiang, T., Jiao, W. J., Li, H. C., Li, Q., Liao, Y. D., … He, J. (2021). Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer. Translational lung cancer research, 10(9), 3713–3736. https://doi.org/10.21037/tlcr-21-634
• 🔗 Racial, sex, and socioeconomic differences between colorectal cancer patients ages 50-75 vs. 75+(Gastro-Intestinal) Stewart O, Williams R, Huston J, Busari K, Gachette D, Meredith K. Racial, sex, and socioeconomic differences between colorectal cancer patients ages 50-75 vs. 75+. Gastroenterology. 2021;160(6)S387–388.
• 🔗 A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previou(Breast) Im, S.-A., Hamilton, E. P., Llombart Cussac, A., Baird, R. D., Ettl, J., Goetz, M. P., Iwata, H., Joy, A. A., Neven, P., Haddad, V., Walding, A. S., Selvi Miralles, M., Bartlett, C. H., & Andre, F. (2021). SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease. Journal of Clinical Oncolog
• 🔗 A Rare Case of a Patient with Hairy Cell Leukemia Developing Blastoid Marginal Zone B Cell Lymphoma.(Hematology) Teklie, Y., Bell, S., Idogun, P., & Venigalla, M. (2021). A Rare Case of a Patient With Hairy Cell Leukemia Developing Blastoid Marginal Zone B-Cell Lymphoma. Cureus, 13(7), e16239. https://doi.org/10.7759/cureus.16239
• 🔗 Comparison of colorectal cancer location and metastasis site in patients aged 50-75 vs. Age 75 and older in community and academic practice.(Gastro-Intestinal) Busari, K. A., Williams, R., Huston, J., Gachette, D., Stewart, O., & Meredith, K. L. (2021). Comparison of colorectal cancer location and metastasis site in patients aged 50 to 75 versus age 75 and older in community and academic practice. Journal of Clinical Oncology, 39(15_suppl), e15595–e15595. https://doi.org/10.1200/JCO.2021.39.15_suppl.e15595
• 🔗 Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors <1 cm.(Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
• 🔗 Demographic differences of colorectal cancer in the community and academic setting in patients over the age of 75 compared to those aged 50 to 75.(Gastro-Intestinal) Busari, K. A., Williams, R., Huston, J., Stewart, O., Gachette, D., & Meredith, K. L. (2021). Demographic differences of colorectal cancer in the community and academic setting in patients over the age of 75 compared to those aged 50 to 75. Journal of Clinical Oncology, 39(15_suppl), e15594–e15594. https://doi.org/10.1200/JCO.2021.39.15_suppl.e15594
• 🔗 Incidence and outcomes of patients >75 years old diagnosed with metastatic colorectal cancer.(Gastro-Intestinal) Schuster C, Busari K, Glasser J, Shridhar R, Huston J, Meredith K. Incidence and outcomes of patients >75 years old diagnosed with metastatic colorectal cancer. Ann Surg Oncol. 2021;28 (Suppl. 1S): 80.
• 🔗 Surgical outcomes and mortality in elderly patients diagnosed with colorectal cancer. Gastroenterology(Gastro-Intestinal) Gachette D, Williams R, Huston J, Busari K, Stewart O, Meredith K. Surgical outcomes and mortality in elderly patients diagnosed with colorectal cancer. Gastroenterology. 2021;160(6) S872-873.
• 🔗 480 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6Gerald Falchook, David Spigel, Manish Patel, Babar Bashir, Susanna Ulahannan, Christine Duffy, Daniela Maier, & Hisaya Azuma. (2021). 480 A first-in-human phase I dose-escalation trial of the B7-H6/CD3 T-cell engager BI 765049 ± ezabenlimab (BI 754091) in patients with advanced solid tumors expressing B7-H6. Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A510. https://doi.org/10.1136/jitc-2021-SITC2021.480
• 🔗 Evaluation of the current treatment strategies for poorly differentiated neuroendocrine tumors. (Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
• 🔗 Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis.(Gastro-Intestinal) Meredith K, Huston J, Shridhar R. Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors: a propensity score matched analysis. HPB. 2021;23 (Suppl 1): 291-2.
• ► 2020 Publications:Research published in 2020:
• 🔗 Acute Bone Pain: An Analysis of Symptom Management Interventions After Administration of Granulocyte-Colony-Stimulating Factors for Myelosuppression(Symptom Management) Mclean E. (2020). Acute Bone Pain: An Analysis of Symptom Management Interventions After Administration of Granulocyte-Colony-Stimulating Factors for Myelosuppression. Clinical journal of oncology nursing, 24(2), 165–169. https://doi.org/10.1188/20.CJON.165-169
• 🔗 A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer.(Breast) Hamilton, E. P., Oliveira, M., Banerji, U., Hernando, C., Garcia-Corbacho, J., Armstrong, A., Ciruelos, E., Patel, M. R., Incorvati, J., Twelves, C., Brier, T., Carroll, D., Fox, S., Klinowska, T., Lindemann, J. P. O., Mather, R., Maudsley, R., McGuinness, S., Sykes, A., & Baird, R. (2020). A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer. Journal of Clinical Oncology, 38(15_suppl),